The lack of data regarding Ki67 expression and other detailed molecular indicators (without which the luminal A and luminal B subtypes could not be properly distinguished according to current standards) only allows us to categorize the patients into four IHC-defined breast cancer subtypes. Here, MKI67 is linked to breast cancer.